Clinical Trials

The Department of Neurology is actively involved in clinical trials to determine the effectiveness of new medications to treat neuromuscular diseases and disorders. If you are interested in receiving additional information or participating in a trial, please e-mail or call the persons listed below. Please note that enrollment is currently closed for some of the trials.

Movement Disorders / Parkinson's Disease - Ongoing Trials
Movement Disorders / Parkinson's Disease - Completed Trials

Multiple Sclerosis (MS) - Ongoing Trials
Multiple Sclerosis (MS) - Completed Trials; data being analyzed
Multiple Sclerosis (MS) - Completed Trials; for historical reference

Neuro-Oncology - Ongoing Trials

Stroke - Ongoing Trials
Stroke - Completed Trials; data being analyzed

Return to the main Patient Care Page

Stroke - Ongoing Trials

RESPECT PFO
	Enrollment is OPEN
	Closure of symptomatic patent foramen ovale (PFO) with the Amplatzer PFO occluder device.
	Principle Investigator:	John Lopez MD, Section of Cardiology
	Participating Neurologists:	James Brorson MD
	Study Coordinator:	Charity Ball and Christi Kordeck, 773-834-4604

RReact (Rapid Response with an Astrocyte modulator in acute Cortical Stroke)
	Enrollment is OPEN
	A new inverstigational therapy for stroke is being tested by our stroke team and at more than 100 hospitals in the United States and Canada. The purpose of the study is to evaluate the safety and effectiveness of an experimental drug that may reduce brain damage caused by a certain type of stroke (a stroke due to a bloot clot, not for hemorrhagic stroke or bleeding in the brain.) The University of Chicago Hospitals will facilitate safe, rapid transport and provide feedback to the referring physician and facility.
	Eligibility Criteria: 18-90 years of age acute ischemic stroke must present to the ER or hospital within 6 hours after the initial onset of stroke symptoms
	Principle Investigator:	Jeffrey Frank MD
	Study Coordinator:	Christi Kordeck